Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review

Sickle cell disease (SCD) is a group of inherited red blood cell disorders affecting millions worldwide. The median life expectancy of someone with SCD remains significantly low despite improvements in standards of care and the implementation of hydroxyurea therapy. Notably, a 20-year interval exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Dick, Maurice H, Abdelgadir, Arowa, Kulkarni, Vaishnavi Vijaya, Akram, Hamna, Chatterjee, Abanti, Pokhrel, Sushil, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187358/
https://www.ncbi.nlm.nih.gov/pubmed/35706735
http://dx.doi.org/10.7759/cureus.24920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187358/
https://www.ncbi.nlm.nih.gov/pubmed/35706735
http://dx.doi.org/10.7759/cureus.24920

Ejemplares similares